[1]
|
L. F. Tseng, “Mechanisms of β-Endorphin-Induced Anti-nociception,” In: L. F. Tseng, Ed., The Pharmacology of Opioid Peptides, Harwood Academia Publishers, Newark, United States, 1995, pp. 249-269.
|
[2]
|
A. Merenlender-Wagner, Y. Dikshtein and G. Yadid, “The β-Endorphin Role in Stress-Related Psychiatric Disorders,” Current Drug Targets, Vol. 10, No. 11, 2009, pp. 1096-1108. http://dx.doi.org/10.2174/138945009789735147
|
[3]
|
S. C. Ribeiro, S. E. Kennedy, Y. R. Smith, C. S. Stohler and J.-K. Zubieta, “Physical and Emotional Stress Regulation through the Endogenous Opioid System and μ-Opioid Receptors,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol. 29, No. 8, 2005, pp. 1264-1280.
http://dx.doi.org/10.1016/j.pnpbp.2005.08.011
|
[4]
|
A. L. O. Hebb, S. Laforest and G. Drolet, “Chapter 4.9 Endogenous Opioids, Stress, and Psychopathology,” Techniques in the Behavioral and Neural Sciences, Vol. 15, 2005, pp. 561-583.
doi.org/10.1016/S0921-0709(05)80031-8
|
[5]
|
A. R. Prossin, T. M. Love, R. A. Koeppa, J. K. Zubieta and K. R. Silk, “Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder,” American Journal of Psychiatry, Vol. 167, No. 8, 2010, pp. 925-933.
http://dx.doi.org/10.1176/appi.ajp.2010.09091348
|
[6]
|
D. Parikh, A. Hamid, T. C Friedman, K. Nguyen, A. Tseng, P. Marquez and K. Lufty, “Stress-Induced Analgesia and Endogenous Opioid Peptides: The Importance of Stress Duration,” European Journal of Pharmacology, Vol. 650, No. 2-3, 2011, pp. 563-567.
http://dx.doi.org/10.1016/j.ejphar.2010.10.050
|
[7]
|
J. Panksepp, B. H. Herman, T. Vilberg, P. Bishop and F. G. DeEskinazi, “Endogenous Opioids and Social Behavior,” Neuroscience & Biobehavioral Reviews, Vol. 4, No. 4, 1980, pp. 473-487.
http://dx.doi.org/10.1016/0149-7634(80)90036-6
|
[8]
|
P. C. Dinas, Y. Koutedakis and A. D. Flouris, “Effects of Exercise and Physical Activity during Depression,” Irish Journal of Medical Science, Vol. 180, No. 2, 2011, pp. 319-325. http://dx.doi.org/10.1007/s11845-010-0633-9
|
[9]
|
L. Hoffman, P. B. Watson, G. Wilson and J. Montgomery, “Low Plasma β-Endorphin in Post-Traumatic Stress Disorder,” Australian and New Zealand Journal of Psychiatry, Vol. 23, No, 2, 1989, pp. 269-273.
http://dx.doi.org/10.3109/00048678909062145
|
[10]
|
G. M. Goodwin, M. P. Austin, S. M. Curran, M. Ross, N. Prentice, K. P. Ebmeier, J. Bennie, S. Carroll and H. Dick, “The Elevation of Plasma Beta-Endorphin Levels in Major Depression,” Journal of Affective Disorders, Vol. 29, No. 4, 1993, pp. 281-289.
http://dx.doi.org/10.1016/0165-0327(93)90018-F
|
[11]
|
M. Leboyer, M. P. Bouvard, C. Recasens, M. H. Plumet, D. Walter-Perotte, F. Tabuteau, F. Bondoux and M. Dugas, “Opiate Hypothesis in Infantile Autism? Therapeutic Trials with Naltrexone,” L’Encephale, Vol. 19, No. 2, 1993, pp. 95-102.
|
[12]
|
M. A. Arnold, D. B. Carr, D. M. Togasaki, M. C. Pian, and J. B. Martin, “Caffeine Stimulates Release in Blood But Not in Cerebrospinal Fluid,” Life Sciences, Vol. 31, No. 10, 1982, pp. 1017-1024.
|
[13]
|
R. H. Khalil and M. R. Soliman, “Diazapam Alters Caffeine-Induced Effects on Beta-Endorphin Levels in Specific Rat Brain Regions,” Life Sciences, Vol. 61, No. 25, 1997, pp. 2485-2490.
http://dx.doi.org/10.1016/S0024-3205(97)00983-1
|
[14]
|
D. M. Veleber and D. I. Templer, “Effects of Caffeine on Anxiety and Depression,” Journal of Abnormal Psychology, Vol. 93, No. 1, 1984, pp. 120-122.
http://dx.doi.org/10.1037/0021-843X.93.1.120
|
[15]
|
K.-F. Shen and S. M. Crain, “Dual Opioid Modulation of the Action Potential Duration of Mouse Dorsal Root Ganglion Neurons in Culture,” Brain Research, Vol. 491, No. 1, 1989, pp. 227-242.
doi:org/10.1016/0006-8993(89)90059-0
|
[16]
|
S. M. Crain and K.-F. Shen, “Modulation of Opioid Analgesia, Tolerance, and Dependence by Gs-Coupled, GM1 Ganglioside-Regulated Opioid Receptor functions,” Trends in Pharmacologic Science, Vol. 19, No. 9, 1998, pp. 358-365. http://dx.doi.org/10.1016/S0165-6147(98)01241-3
|
[17]
|
S. Crain and S. M. Crain, “Endorphinergic Attenuation of Distress by Concomitantly Enhancing Endogenous Opioid Release and Switching Opioid Receptor Signaling from an Excessively Excitatory to a Normal Inhibitory Mode,” Journal of Behavioral and Brain Research, Vol. 3, in Press.
|
[18]
|
S. M. Crain and K.-F. Shen, “Antagonists of Excitatory Opioid Receptor Functions Enhance Morphine’s Analgesic Potency and Attenuate Opioid Tolerance/Dependence Liability,” Pain, Vol. 84, No. 2-3, 2000, pp. 121-131.
http://dx.doi.org/10.1016/S0304-3959(99)00223-7
|
[19]
|
S. M. Crain and K.-F. Shen, “Neuraminidase Inhibitor, Oseltamivir Blocks GM1 Ganglioside-Regulated Excitatory Opioid Receptor-Mediated Hyperalgesia, Enhances Opioid Analgesia and Attenuates Tolerance in Mice,” Brain Research, Vol. 995, No. 2, 2004, pp. 260-266.
http://dx.doi.org/10.1016/j.brainres.2003.09.068
|
[20]
|
S. M. Crain and K.-F. Shen, “Low Doses of Cyclic AMP-Phosphodiesterase Inhibitors Rapidly Evoke Opioid-Mediated Thermal Hyperalgesia in Naive Mice Which Is Converted to Prominent Analgesia by Cotreatment with Ultra-Low-Dose Naltrexone,” Brain Research, Vol. 1231, 2008, pp. 16-24.
http://dx.doi.org/10.1016/j.brainres.2008.07.015
|
[21]
|
S. Crain, W. Crain, S. M. Crain and M. Crain, “Methods and Compositions for Treating Distress Dysfunction and Enhancing Safety and Efficacy of Specific Medications,” USPTO Patent 8372414, February 12, 2013.
|
[22]
|
S. F. LaVincente, J. M. White, A. A. Somogyi, F. Bochner and C. B. Chapleo, “Enhanced Buprenorphine Analgesia with the Addition of Ultra-Low-Dose Naloxone in Healthy Subjects,” Clinical Pharmacology & Therapeutics, Vol. 83, No. 1, 2007, pp. 144-152.
|
[23]
|
C. S. Yuan, T. Karrison, J. A. Wu, T. K. Lowell, J. P. Lynch and J. F. Foss, “Dose-Related Effects of Oral Acetaminophen on Cold-Induced Pain: A Double-Blind, Randomized Placebo-Controlled Trial,” Clinical Pharmacology and Therapeutics, Vol. 63, No. 3, 1998, pp. 379-383. http://dx.doi.org/10.1016/S0009-9236(98)90169-2
|
[24]
|
Z. D. Cooper, M. A. Sullivan, S. K. Vosburgm, J. M. Manubay, M. Haney, R. W. Foltin, S. M. Evans, W. J. Kowalczyk, P. A. Saccone and S. D. Corner, “Effects of Repeated Oxycodone Administration on Its Analgesic and Subjective Effects in Normal, Healthy Volunteers,” Behavioral Pharmacology, Vol. 23, No. 3, 2012, pp. 271-279. http://dx.doi.org/10.1097/FBP.0b013e3283536d6f
|
[25]
|
G. J. McKenna, “Methadone and Opiate Drugs: Psychotropic Effect and Self-Medication,” Annals of the New York Academy of Sciences, Vol. 398, 1982, pp. 44-55. http://dx.doi.org/10.1111/j.1749-6632.1982.tb39472.x
|
[26]
|
C. France and B. Ditto, “Cardiovascular Responses to the Combination of Caffeine and Mental Arithmetic, Cold Pressor, and Static Exercise Stressors,” Psychophysiology, Vol. 29, No. 3, 1992, pp. 272-282.
http://dx.doi.org/10.1111/j.1469-8986.1992.tb01698.x
|
[27]
|
B. Meier, “Pain Killer: A Wonder Drug’s Trail of Addiction and Death,” Rodale Press, Emmaus, 2003.
|
[28]
|
E. Nestler, “Historical Review: Molecular and Cellular Mechanisms of Opiate and Cocaine Addiction,” Trends in Pharmacological Sciences, Vol. 25, No. 4, 2004, pp. 210-218. http://dx.doi.org/10.1016/j.tips.2004.02.005
|
[29]
|
S. M. Crain and K.-F. Shen, “Chronic Morphine-Treated Sensory Ganglion Neurons Remain Supersensitive to the Excitatory Effects of Naloxone for Months after Return to Normal Culture Medium: An in Vitro Model of ‘Protracted Opioid Dependence,’” Brain Research, Vol. 694, No. 1-2, 1995, pp. 103-110.
|
[30]
|
J. T. Slattery, J. M. Wilson, T. F. Kalhorn and S. D. Nelson, “Dose-Dependent Pharmacokinetics of Acetaminophen: Evidence of Glutathione Depletion in Humans,” Clinical Pharmacology and Therapeutics, Vol. 41, 1987, pp. 413-418. http://dx.doi.org/10.1038/clpt.1987.50
|
[31]
|
M. Hadijconstantinou and N. H. Neff, “Nicotine and Endogenous Opioids: Neurochemical and Pharmacological Evidence,” Neuropharmacology, Vol. 60, No. 7-8, 2011, pp. 1209-1220.
http://dx.doi.org/10.1016/j.neuropharm.2010.11.010
|
[32]
|
J. M. Mitchell, J. P. O’Neil, M. Janabi, S. M. Marks, W. J. Jagust and H. L. Fields, “Alcohol Consumption Induces Endogenous Opioid Release in the Human Orbitofrontal Cortex and Nucleus Accumbens,” Science Translational Medicine, Vol. 4, No. 116, 2012, p. 116ra6.
http://dx.doi.org/10.1126/scitranslmed.3002902
|
[33]
|
H. Teschemacher, G. Koch and V. Brantl, “Milk ProteinDerived Opioid Receptor Ligands,” Biopolymers (Peptide Science), Vol. 43, No. 2, 1997, pp. 99-117.
http://dx.doi.org/10.1002/(SICI)1097-0282(1997)43:2<99::AID-BIP3>3.0.CO;2-V
|
[34]
|
F. R. Huebner, K. W. Lieberman, R. P. Rubino and J. S. Wall, “Demonstration of High Opioid-Like Activity in Isolated Peptides from Wheat Gluten Hydrolysates,” Peptides, Vol. 5, No. 6, 1984, pp. 1139-1147.
http://dx.doi.org/10.1016/0196-9781(84)90180-3
|
[35]
|
C. Colantuani, P. Rada, J. McCarthy, C. Patten, N. Avena, A. Chadeayne and B. Hoebel, “Evidence That Intermittent, Excessive Sugar Intake Causes Endogenous Opioid Dependence,” Obesity Research, Vol. 10, No. 6, 2002, pp. 478-488. http://dx.doi.org/10.1038/oby.2002.66
|
[36]
|
N. M. Avena, P. Rada and B. G. Hoebel, “Evidence for Sugar Addiction: Behavioral and Neurochemical Effects of Intermittent, Excessive Sugar Intake,” Neuroscience and Biobehavioral Reviews, Vol. 32, No. 1, 2008, pp. 20-39. http://dx.doi.org/10.1016/j.neubiorev.2007.04.019
|
[37]
|
S. Seneff, R. Davidson and L. Mascitelli, “Might Cholesterol Sulfate Deficiency Contribute to the Development of Autistic Spectrum Disorder?” Medical Hypotheses, Vol. 78, No. 2, 2012, pp. 213-217.
http://dx.doi.org/10.1016/j.mehy.2011.10.026
|
[38]
|
C. B. Pert, “Molecules of Emotion,” Scribner, New York, 1997.
|
[39]
|
C. F. Levinthal, “Messengers of Paradise: Opiates and the Brain,” Doubleday, New York, 1988.
|
[40]
|
J. Panksepp, “A Neurochemical Theory of Autism,” Trends in Neuroscience, Vol. 2, 1979, pp. 174-177.
|
[41]
|
F. G. Bowling, H. S. Heussler, A. McWhinney and P. A. Dawson, “Plasma and Urinary Sulfate Determination in a Cohort with Autism,” Biochemical Genetics, Vol. 51, No, 1-2, 2013, pp. 147-153.
http://dx.doi.org/10.1007/s10528-012-9550-0
|
[42]
|
R. H. Waring and L. V. Klovrza, “Sulphur Metabolism in Autism,” Journal of Nutritional and Environmental Medicine, Vol. 10, No. 1, 2000, pp. 25-32.
http://dx.doi.org/10.1080/13590840050000861
|
[43]
|
A. Lekman, O. Skjeidal, E. Sponheim and L. Svennerholm, “Gangliosides in Children with Autism,” Acta Paediatrica, Vol. 84, No. 7, 1995, pp. 787-790.
http://dx.doi.org/10.1111/j.1651-2227.1995.tb13757.x
|
[44]
|
P. Good, “Did Acetaminophen Provoke the Autism Epidemic?” Alternative Medicine Review, Vol. 14, No. 4, 2009, pp. 364-372.
|
[45]
|
G. Christopher, “Endogenous Opioids and Opiate Antagonists in Autism: Brief Review of Empirical Findings and Implications for Clinicians,” Developmental Medicine & Child Neurology, Vol. 37, No. 3, 1995, pp. 239-245.
http://dx.doi.org/10.1111/j.1469-8749.1995.tb11998.x
|
[46]
|
A. Y. Hardan, L. K. Fung, R. A. Libove, T. V. Obukhanych, S. Nair, L. A. Herzenberg, T. W. Frazier and R. Tirouvanziam, “A Randomized Controlled Pilot Trial of oral N-Acetylcysteine in Children with Autism,” Biolo-gical Psychiatry, Vol. 71, No. 11, 2012, pp. 956-961.
http://dx.doi.org/10.1016/j.biopsych.2012.01.014
|
[47]
|
C. M. Pennesi and L. C. Klein, “Effectiveness of the Gluten-Free, Casein-Free Diet for Children Diagnosed with Autism Spectrum Disorder: Based on Parental Report,” Nutritional Neuroscience, Vol. 15, No. 2, 2012, pp. 85-91.
http://dx.doi.org/10.1179/1476830512Y.0000000003
|
[48]
|
G. Dichter, C. A. Damiano and J. S. Allen, “Reward Circuitry Dysfunction in Psychiatric and Developmental Disorders and Genetic Syndromes: Animal Models and Clinical Findings,” Journal of Neurodevelopmental Disorders, Vol. 4, No. 19, 2012, pp. 1-43.
http://dx.doi.org/10.1186/1866-1955-4-19
|
[49]
|
O. Dean, F. Giorlando and M. Berk, “N-Acetylcysteine in Psychiatry: Current Therapeutic Evidence and Potential Mechanisms of Action,” Journal of Psychiatry and Neuroscience, Vol. 36, No. 2, 2011, pp. 78-86.
|
[50]
|
M. Berk, G. S. Malhi, L. J. Gray and O. M. Dean, “The promise of N-Acetylcysteine in Neuropsychiatry,” Trends in Pharmacological Science, Vol. 34, No. 3, 2013, pp. 167-177. http://dx.doi.org/10.1016/j.tips.2013.01.001
|